spironolactone has been researched along with drospirenone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Buse, M; Casals-Stenzel, J; Losert, W | 1 |
| Mikacich, JA; Rapkin, AJ | 1 |
| Kroll, R; Rapkin, AJ | 1 |
| Ciurea, A; Krunic, A; Scheman, A | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Arias-Loza, PA; Blode, H; Elmore, SA; Ertl, G; Fritzemeier, KH; Hegele-Hartung, C; Hu, K; Maronpot, R; Muehlfelder, M; Pelzer, T | 1 |
| Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
| Borden, SA; Kolkhof, P | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
| Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
| Antelmi, A; Armani, A; Canese, R; Caprio, M; Carpinelli, G; Cinti, F; Cinti, S; Cranston, GA; Fabbri, A; Malorni, W; Marconi, M; Marzolla, V; Matarrese, P; Morgan, J; Pagotto, U; Quarta, C; Rosano, G; Young, MJ | 1 |
| Acosta, K; Chavez-Riveros, A; Nickisch, K; Santhamma, B | 1 |
| Channar, PA; El-Seedi, H; Faisal, M; Larik, FA; Mehfooz, H; Saeed, A; Shahzad, D | 1 |
4 review(s) available for spironolactone and drospirenone
| Article | Year |
|---|---|
Premenstrual syndrome in adolescents: diagnosis and treatment.
Topics: Adolescent; Androstenes; Calcium; Female; Humans; Mood Disorders; Patient Education as Topic; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2006 |
Treatment of premenstrual disorders.
Topics: Alprazolam; Androstenes; Cognitive Behavioral Therapy; Contraceptives, Oral; Exercise; Female; Gonadotropin-Releasing Hormone; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Spironolactone; Treatment Outcome | 2006 |
Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics.
Topics: Androstenes; Animals; Eplerenone; Humans; Mineralocorticoid Receptor Antagonists; Models, Biological; Models, Molecular; Molecular Targeted Therapy; Receptors, Mineralocorticoid; Spironolactone | 2012 |
Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives.
Topics: Aldosterone; Androstadienes; Androstenes; Animals; Canrenone; Chloranil; Dehydroepiandrosterone; Eplerenone; Humans; Molecular Structure; Receptors, Mineralocorticoid; Spironolactone | 2017 |
1 trial(s) available for spironolactone and drospirenone
| Article | Year |
|---|---|
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
9 other study(ies) available for spironolactone and drospirenone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Progestogens with antimineralocorticoid activity.
Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1985 |
Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Topics: Acne Vulgaris; Adult; Androgen Receptor Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Prospective Studies; Spironolactone; Treatment Outcome | 2008 |
Effects of drospirenone on cardiovascular markers in human aortic endothelial cells.
Topics: Adolescent; Aldosterone; Androstenes; Aorta; Biomarkers; Cardiotonic Agents; Cardiovascular System; Cells, Cultured; Chemokine CCL2; Coronary Vessels; E-Selectin; Endothelial Cells; Female; Humans; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Progesterone; Progesterone Congeners; Promegestone; Spironolactone | 2009 |
Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.
Topics: Aldosterone; Androstenes; Animals; Blood Pressure; Epithelial Sodium Channels; Estradiol; Female; Hypertrophy; Kidney; Kidney Diseases; Medroxyprogesterone Acetate; Oxidative Stress; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Cytoplasmic and Nuclear; Sodium Chloride; Spironolactone | 2009 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Aldosterone; Androstenes; Animals; Autophagy; Body Composition; Cell Transdifferentiation; Cells, Cultured; Diet, High-Fat; Female; Gene Expression Profiling; Glucose Intolerance; Inguinal Canal; Intra-Abdominal Fat; Ion Channels; Macrolides; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Mitochondrial Proteins; Obesity; Receptors, Mineralocorticoid; Spironolactone; Uncoupling Protein 1; Up-Regulation; Weight Gain | 2014 |
A new approach towards the synthesis of drospirenone and steroidal spirolactones.
Topics: Androstenes; Spironolactone | 2015 |